Du är här

Hem

Autism spectrum conditions in myotonic dystrophy type 1: a study on 57 individuals with congenital and childhood forms.

TitelAutism spectrum conditions in myotonic dystrophy type 1: a study on 57 individuals with congenital and childhood forms.
Publication TypeJournal Article
Year of Publication2008
AuthorsEkström, A-B, Hakenäs-Plate, L, Samuelsson, L, Tulinius, Már, Wentz, E
JournalAmerican journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
Volume147B
Issue6
Pagination918-26
Date Published2008 Sep 5
ISSN1552-485X
NyckelordAdolescent, Adult, Age of Onset, Algorithms, Autistic Disorder, Child, Child, Preschool, Comorbidity, Female, Humans, Inheritance Patterns, Intelligence, Male, Mental Disorders, Mental Processes, Myotonic Disorders, Protein-Serine-Threonine Kinases, Trinucleotide Repeat Expansion
Abstrakt

Myotonic dystrophy type 1 (DM1) is an autosomal dominant disorder, caused by an expansion of a CTG triplet repeat in the DMPK gene. The aims of the present study were to classify a cohort of children with DM1, to describe their neuropsychiatric problems and cognitive level, to estimate the size of the CTG expansion, and to correlate the molecular findings with the neuropsychiatric problems. Fifty-seven children and adolescents (26 females; 31 males) with DM1 (CTG repeats > 40) were included in the study. The following instruments were used: Autism Diagnostic Interview-Revised (ADI-R), 5-15, Griffiths Mental Development Scales, and the Wechsler Scales. Based on age at onset and presenting symptoms, the children were divided into four DM1 groups; severe congenital (n = 19), mild congenital (n = 18), childhood (n = 18), and classical DM1 (n = 2). Forty-nine percent had an autism spectrum disorder (ASD) and autistic disorder was the most common diagnosis present in 35% of the subjects. Eighty-six percent of the individuals with DM1 had mental retardation (MR), most of them moderate or severe MR. ASD was significantly correlated with the DM1 form; the more severe the form of DM1, the higher the frequency of ASD. The frequency of ASD increased with increasing CTG repeat expansions. ASD and/or other neuropsychiatric disorders such as attention deficit hyperactivity disorder, and Tourette's disorder were found in 54% of the total DM1 group. In conclusion, awareness of ASD comorbidity in DM1 is essential. Further studies are warranted to elucidate the molecular etiology causing neurodevelopmental symptoms such as ASD and MR in DM1.

DOI10.1002/ajmg.b.30698
Custom 1

http://www.ncbi.nlm.nih.gov/pubmed/18228241?dopt=Abstract

Custom 6

lpsof

Alternate JournalAm. J. Med. Genet. B Neuropsychiatr. Genet.
PubMed ID18228241
Undefined